Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Rule 8.4 Announcement

8 Aug 2008 12:00

RNS Number : 9656A
SiRViS IT Holdings Limited
08 August 2008
 



SIRVIS IT HOLDINGS LIMITED

Rule 8.4 Announcement

Further to the announcement on 4 August 2008, in relation to the recommended cash offer for SiRViS IT plc to be made by Strand Partners on behalf of SiRViS IT Holdings Limited (the Rule 2.5 Announcement) and the announcement, issued on 5 August 2008, in accordance with Rule 8.1 of the City Code in relation to the purchase by Trident Private Equity Fund II LP ("TPEII") of 980,000 SiRViS IT Shares, representing approximately 29.70 per cent. of the total share capital of SiRViS IT, from Oryx International Growth Fund Limited, SiRViS IT Holdings makes the following disclosure in accordance with Rule 8.4 of the City Code.

SiRViS IT Holdings has received an irrevocable undertaking from TPEII (the "TPEII Irrevocable") in respect of the 980,000 SiRViS IT Shares it acquired from Oryx, representing approximately 29.70 per cent. of the total share capital of SiRViS IT. The irrevocable undertaking will only cease to be binding if a competing offer is made by another party for the entire issued share capital of SiRViS IT which exceeds 170 pence per SiRViS IT Share and is recommended for acceptance by the Independent Directors. The irrevocable undertaking commits TPEII to accept the offer within eighteen days of the issue of the Offer Document.

As the TPEII Irrevocable directly replaces the irrevocable undertaking previously received from NAV LLP (on behalf of Oryx), which was disclosed in the Rule 2.5 Announcement on 4 August 2008, there has been no change to the level of irrevocable undertakings to accept the Offer that SiRViS IT Holdings has received, which remains at 1,926,331 SiRViS IT Shares, representing approximately 58.37 per cent. of SiRViS IT's total share capital.

Terms defined in the Rule 2.5 Announcement have the same meanings as in this announcement.

SiRViS IT Holdings Limited

Tel: (020) 7747 5678

Jeremy Brade, Director

James Agnew, Director

Strand Partners Limited 

(Financial Adviser to NAV LLP and SiRViS IT Holdings)

Tel: (020) 7409 3494

Stuart Faulkner

Matthew Chandler

Victoria Milne-Taylor

Strand Partners, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for SiRViS IT Holdings and no one else in connection with the Offer and is not advising any other person and accordingly will not be responsible to anyone other than SiRViS IT Holdings for providing the protections afforded to clients of Strand Partners nor for providing advice in relation to the Offer, the contents of this announcement or any other matter or arrangement referred to herein. No liability whatsoever is accepted by Strand Partners for the accuracy of any information or opinion contained in this announcement or for the omission of any material information, for which Strand Partners is not responsible.

The Offer will not be made, directly or indirectly, in, into or from the United States, Canada, Australia, South Africa or Japan or any other jurisdiction, or by the use of the mails of, or by any means or instrumentality (including, without limitation, by means of facsimile transmission, telex, telephone, internet or other forms of electronic communication) of interstate or foreign commerce of, or by any facility of a national, state or other securities exchange of, the United States, or in, into or from Canada, Australia, South Africa or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.

This announcement does not constitute an offer in the United StatesCanadaAustraliaSouth Africa or Japan or any such other jurisdiction and the Offer will not be capable of acceptance by any such use, means, instrumentality or facilities or otherwise from or within the United StatesCanadaAustraliaSouth Africa or Japan or any such other jurisdiction. Accordingly, this announcement is not being, and should not be, directly or indirectly mailed, transmitted or otherwise distributed or sent into, in whole or in part, in or into or from the United States, Canada, Australia, South Africa or Japan or any such other jurisdiction.

The distribution of this announcement and availability of the Offer to persons not resident in, nor citizens of, the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are citizens or in which they are resident. Such Overseas Shareholders should inform themselves about, and observe, any applicable legal or regulatory requirements of any such relevant jurisdiction. This announcement has been prepared for the purposes of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England. Any person (including, without limitation, nominees, trustees and custodians) who would, or otherwise intend to, forward this announcement, the Offer Document and/or the Form of Acceptance or any accompanying document to any jurisdiction outside the United Kingdom should refrain from doing so and seek appropriate professional advice before doing so.

Neither the United States Securities and Exchange Commission nor any state securities commission has reviewed, approved or disapproved this announcement or any of the proposals described in this announcement.

The directors of SiRViS IT Holdings accept responsibility for all of the information contained in this announcement. To the best of the knowledge and belief of the directors of SiRViS IT Holdings (each of whom has taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they are responsible is in accordance with the facts and does not omit anything likely to affect the import of such information. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPEAEPPESEPEFE
Date   Source Headline
4th Jun 20264:56 pmRNSNet Asset Value(s)
1st Jun 20265:03 pmRNSNet Asset Value(s)
26th May 20264:26 pmRNSNet Asset Value(s)
18th May 20265:17 pmRNSNet Asset Value(s)
11th May 20264:46 pmRNSNet Asset Value(s)
11th May 20267:53 amRNSNet Asset Value(s)
7th May 20267:00 amRNSWeekly Net Asset Value Reporting
21st Apr 202610:00 amRNSDirector/PDMR Shareholding
20th Apr 20269:43 amRNSDirector/PDMR Shareholding
16th Apr 20269:37 amRNSProposed acquisition of Animalcare Group Plc
13th Apr 20262:16 pmRNSDirector/PDMR Shareholding
13th Apr 20262:05 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:55 pmRNSDirector/PDMR Shareholding
10th Apr 20264:48 pmRNSNet Asset Value(s)
27th Mar 20267:00 amRNSAppointment of new Chairman
23rd Mar 202610:29 amRNSPassing of the Chairman
9th Mar 202611:19 amRNSNet Asset Value(s)
11th Feb 202610:37 amRNSEGM Requisition
9th Feb 20269:08 amRNSNet Asset Value(s)
3rd Feb 20261:46 pmRNSNet Asset Update
30th Jan 202610:02 amRNSPotential Bid for Pinewood Technologies Group Plc
22nd Jan 20269:40 amRNSBid for Kitwave Plc
9th Jan 20264:31 pmRNSNet Asset Value(s)
10th Dec 20257:00 amRNSHalf-year Financial Report
8th Dec 202510:55 amRNSNet Asset Value(s)
10th Nov 20253:40 pmRNSNet Asset Value(s)
9th Oct 20253:13 pmRNSNet Asset Value(s)
18th Sep 20251:47 pmRNSChange of Corporate Broker
9th Sep 20257:00 amRNSInvestor Presentation
8th Sep 202511:15 amRNSNet Asset Value(s)
20th Aug 202511:03 amRNSResult of AGM
8th Aug 202512:22 pmRNSNet Asset Value(s)
23rd Jul 20254:13 pmRNSNotice of AGM
10th Jul 202512:06 pmRNSDirector/PDMR Shareholding
9th Jul 20251:54 pmRNSNet Asset Value(s)
7th Jul 20257:00 amRNSAnnual Financial Report
10th Jun 202512:16 pmRNSNet Asset Value(s)
4th Jun 20254:18 pmRNSDirector/PDMR Shareholding
12th May 20251:12 pmRNSNet Asset Value(s)
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
8th Apr 20252:41 pmRNSNet Asset Value(s)
18th Mar 20259:22 amRNSDirector/PDMR Shareholding
10th Mar 20255:56 pmRNSNet Asset Value(s)
17th Feb 20253:45 pmRNSDirector/PDMR Shareholding
10th Feb 202511:35 amRNSNet Asset Value(s)
4th Feb 20253:07 pmRNSDirector/PDMR Shareholding
20th Jan 20254:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.